Molecular profiling of Asian patients with advanced melanoma receiving check-point inhibitor treatment

OBJECTIVE: Melanoma is major medical challenge and being able to monitor treatment response is critical. This study aimed to use molecular profiling of Asian patients with advanced melanoma who were receiving treatment with check-point inhibitors (CPIs) to identify novel biomarkers of tumor response...

Descripción completa

Detalles Bibliográficos
Autores principales: Byeon, S., Cho, H.J., Jang, K.-T., Kwon, M., Lee, J., Kim, S.T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910729/
https://www.ncbi.nlm.nih.gov/pubmed/33399091
http://dx.doi.org/10.1016/j.esmoop.2020.100002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910729/
https://www.ncbi.nlm.nih.gov/pubmed/33399091
http://dx.doi.org/10.1016/j.esmoop.2020.100002

Ejemplares similares